These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
417 related items for PubMed ID: 1382781
1. Pharmacological characterization of non-NMDA subtypes of glutamate receptor in the neonatal rat hemisected spinal cord in vitro. Zeman S, Lodge D. Br J Pharmacol; 1992 Jun; 106(2):367-72. PubMed ID: 1382781 [Abstract] [Full Text] [Related]
2. Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5H-2,3-benzodiaze pine (GYKI 52466). Parsons CG, Gruner R, Rozental J. Neuropharmacology; 1994 May; 33(5):589-604. PubMed ID: 7523977 [Abstract] [Full Text] [Related]
3. A comparison of the actions of agonists and antagonists at non-NMDA receptors of C fibres and motoneurones of the immature rat spinal cord in vitro. Pook P, Brugger F, Hawkins NS, Clark KC, Watkins JC, Evans RH. Br J Pharmacol; 1993 Jan; 108(1):179-84. PubMed ID: 8094024 [Abstract] [Full Text] [Related]
12. Antagonist profile of 6,7-dichloro-3-hydroxy-2-quinoxalinecarboxylate at excitatory amino acid receptors in the neonatal rat spinal cord. Birch PJ, Grossman CJ, Hayes AG. Eur J Pharmacol; 1989 Apr 12; 163(1):127-31. PubMed ID: 2545458 [Abstract] [Full Text] [Related]
13. A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy. Löscher W, Lehmann H, Behl B, Seemann D, Teschendorf HJ, Hofmann HP, Lubisch W, Höger T, Lemaire HG, Gross G. Eur J Neurosci; 1999 Jan 12; 11(1):250-62. PubMed ID: 9987029 [Abstract] [Full Text] [Related]
16. Modulation of AMPA and NMDA responses in rat spinal dorsal horn neurons by trans-1-aminocyclopentane-1,3-dicarboxylic acid. Cerne R, Randic M. Neurosci Lett; 1992 Sep 14; 144(1-2):180-4. PubMed ID: 1279484 [Abstract] [Full Text] [Related]
17. Competitive inhibition by NBQX of kainate/AMPA receptor currents and excitatory synaptic potentials: importance of 6-nitro substitution. Randle JC, Guet T, Cordi A, Lepagnol JM. Eur J Pharmacol; 1992 May 14; 215(2-3):237-44. PubMed ID: 1382998 [Abstract] [Full Text] [Related]
18. NBQX inhibits AMPA-induced locomotion after injection into the nucleus accumbens. Boldry RC, Kelland MD, Engber TM, Chase TN. Brain Res; 1993 Jan 15; 600(2):331-4. PubMed ID: 7679606 [Abstract] [Full Text] [Related]
19. NMDA, kainate, and AMPA depolarize nondopamine neurons in the rat ventral tegmentum. Wang T, French ED. Brain Res Bull; 1995 Jan 15; 36(1):39-43. PubMed ID: 7533638 [Abstract] [Full Text] [Related]
20. In-vitro characterization of YM872, a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist. Kohara A, Okada M, Tsutsumi R, Ohno K, Takahashi M, Shimizu-Sasamata M, Shishikura J, Inami H, Sakamoto S, Yamaguchi T. J Pharm Pharmacol; 1998 Jul 15; 50(7):795-801. PubMed ID: 9720630 [Abstract] [Full Text] [Related] Page: [Next] [New Search]